Dec 25th 2013 was a special Christmas Day for Suining central hospital which located in Sichuan, China, because they finished the 1000 cases in their HIFU(High Intensity Focused Ultrasound) center. Dr. Chen Yongjun, the president of the hospital and Dr. He jia, the director of the HIFU center attend the treatment of the 1000 patient. After the treatment, the clapping impress everybody’s exciting.
The Suining central hospital installed the first JC200 Focused Ultrasound Tumor Therapeutic System in Oct 29th , 2010. In the November and December of 2010, they treated 61 cases. This number increased to over 1000 in 2013 which is more than the sum from 2010-2012.
Dr. Hejia, the director of the HIFU center of Suining central hospital said there are 3 factors increased the cases number so rapidly. First, HIFU is a real noninvasive therapy which really minimized the harm to patients as well as to their uterus during the treatment. This improve the patient’s life quality significantly. Secondly, a careful and strict selection of patients which was the guarantee of effectiveness and safety in the treatment. Third, Dr. Hejia said that the management of the hospital and Haifu team gave enough support during the operation of the HIFU center.
In South Korea, the Gang-Nam St. Peter’s Hospital also have exciting numbers of treated patients. In 2012, they treated 385 patients with Haifu Model JC Focused Ultrasound Tumor Therapeutic System, the number increased to 548 in 2013. Most of the treated patients are uterine fibroids patients.
Dr.Kim Taehee, the leader of Haifu Knife Tumor Therapeutic Center in Gang-Nam St. Peter’s Hospital, he said the follow-up of patients treated with HIFU has been carried out in accordance with a specific clinical trial protocol developed for this technology and approved by competent instances. Patient response has been very positive, showing a substantial increase in the patients’ quality of life. Dr. Kim also mentioned that the Haifu Model JC Focused Ultrasound Tumor Therapeutic System has been shown to be a effective and safe modality for non-invasive tumor treatment.
